



Enzymatic Synthesis and Characterization of Different Families
of Chitooligosaccharides and Their Bioactive Properties
Noa Miguez 1, Peter Kidibule 2 , Paloma Santos-Moriano 1,3, Antonio O. Ballesteros 1, Maria Fernandez-Lobato 2
and Francisco J. Plou 1,*


Citation: Miguez, N.; Kidibule, P.;
Santos-Moriano, P.; Ballesteros, A.O.;
Fernandez-Lobato, M.; Plou, F.J.
Enzymatic Synthesis and
Characterization of Different Families
of Chitooligosaccharides and Their
Bioactive Properties. Appl. Sci. 2021,
11, 3212. https://doi.org/10.3390/
app11073212
Academic Editor: Carl Grey
Received: 12 March 2021
Accepted: 1 April 2021
Published: 3 April 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Instituto de Catálisis y Petroleoquímica, CSIC, 28049 Madrid, Spain; noa.miguez@csic.es (N.M.);
palomacarmen.santos@universidadeuropea.es (P.S.-M.); a.ballesteros@icp.csic.es (A.O.B.)
2 Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Departamento de Biología Molecular, Universidad
Autónoma de Madrid, 28049 Madrid, Spain; pkidibule@cbm.csic.es (P.K.); mfernandez@cbm.csic.es (M.F.-L.)
3 Department of Health Sciences, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid,
Villaviciosa de Odón, 28670 Madrid, Spain
* Correspondence: fplou@icp.csic.es
Abstract: Chitooligosaccharides (COS) are homo- or hetero-oligomers of D-glucosamine (GlcN)
and N-acetyl-D-glucosamine (GlcNAc) that can be obtained by chitosan or chitin hydrolysis. Their
enzymatic production is preferred over other methodologies (physical, chemical, etc.) due to the mild
conditions required, the fewer amounts of waste and its efficiency to control product composition.
By properly selecting the enzyme (chitinase, chitosanase or nonspecific enzymes) and the substrate
properties (degree of deacetylation, molecular weight, etc.), it is possible to direct the synthesis
towards any of the three COS types: fully acetylated (faCOS), partially acetylated (paCOS) and fully
deacetylated (fdCOS). In this article, we review the main strategies to steer the COS production
towards a specific group. The chemical characterization of COS by advanced techniques, e.g.,
high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-
PAD) and MALDI-TOF mass spectrometry, is critical for structure–function studies. The scaling of
processes to synthesize specific COS mixtures is difficult due to the low solubility of chitin/chitosan,
the heterogeneity of the reaction mixtures, and high amounts of salts. Enzyme immobilization can
help to minimize such hurdles. The main bioactive properties of COS are herein reviewed. Finally,
the anti-inflammatory activity of three COS mixtures was assayed in murine macrophages after
stimulation with lipopolysaccharides.
Keywords: sustainable chemistry; biocatalysis; aminopolysaccharides; chitin; chitosan; chitooligosac-
charides; chitinases; chitosanases; bioactive oligosaccharides; N-acetyl-glucosamine
1. Introduction
Chitin, an aminopolysaccharide composed of N-acetyl-D-glucosamine (GlcNAc) units
linked by β(1 4) bonds, is the second most abundant polymer in nature and can be found
in fungal cell walls and the exoskeletons of arthropods (crustaceans, mollusks, insects,
etc.) [1]. Total or partial deacetylation of chitin yields chitosan, a cationic polysaccharide
is consisting of variable amounts of D-glucosamine (GlcN) and GlcNAc moieties [2]. In
general, when the degree of acetylation of the polymer surpasses 30%, it is considered chitin,
and if it is lower than 30%, it is considered chitosan [3]. To minimize the waste derived
from chitin’s chemical deacetylation, the development of chitin deacetylases (EC 3.5.1.41)
offers a greener alternative [4].
Both chitin and chitosan exhibit an interesting range of physicochemical and biological
properties with numerous applications to the food, cosmetic, agriculture, textile and
biomedical industries [5,6]. However, their use is often limited by their viscosity and poor
aqueous solubility.
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Chitooligosaccharides (COS), the hydrolyzed products of chitin or chitosan, are homo-
or hetero-oligomers of GlcN and/or GlcNAc linked by β(1→4) bonds [7,8]. Generally,
COS has a degree of polymerization (DP) up to 20 and an average molecular weight
(MW) lower than 3.9 kDa. They are water-soluble and possess many interesting biological
activities [9–14]. Unlike chitosan, COS can be absorbed in the gastrointestinal tract and
enter the bloodstream [15]. The biodegradability of chitosan and their derivatives has
been correlated with the presence in human tissues of lysozyme, a glycosyl hydrolase
that can hydrolyze β(1→4) linkages in these molecules [16]. COS are high value-added
products with great potential in many areas, including agriculture, cosmetics, functional
foods, pharmacy and medicine [13,17–19].
According to their composition, COS can be classified into three different types
(Figure 1) [20]: fully acetylated chitooligosaccharides (faCOS) (composed exclusively of
GlcNAc residues), partially acetylated chitooligosaccharides (paCOS) (formed by GlcN and
GlcNAc units), and fully deacetylated chitooligosaccharides (fdCOS) (composed of GlcN
residues only). Interestingly, COS can exhibit different degrees of polymerization (DP),
degrees of deacetylation (DD) and patterns of acetylation (PA), which results in different
biological properties [2]. COS obtained by hydrolysis of chitin or chitosan are heteroge-
neous mixtures of products, which explains the poor reproducibility and divergent results
when their biological properties are tested. Hence, the preparation of well-depicted COS
is necessary for a better understanding of their biological properties and the analysis of
structure–activity relationships and decipher the molecular mechanisms behind them [3].
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Figure 1. Types of chitooligosaccharides (COS): fully deacetylated (fdCOS), partially acetylated 
(paCOS) and fully acetylated (faCOS). 
This review is focused on the different approaches for the enzymatic preparation of 
COS, their characterization, and the influence of COS composition on their anti-inflam-
matory properties. 
2. Chitooligosaccharides Production 
i . Types of chit oligosa charides (COS): fully deacetylated (fdCOS), p rtially acetylated
( ) f ll acet late (fa S).
his revie is foc se on the ifferent a roaches for the enzy atic re aration of
S, their characterization, and the influence of COS composition on their anti-inflammatory
properties.
2. Chitooligosaccharides Production
Several technological approaches employed for the preparation of COS are summa-
rized in Figure 2. The production of COS can be achieved by physical, chemical and
enzymatic methods or a combination of them.
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Physical methods for chitin or chitosan hydrolysis include ultrasonication, hydrother-
mal tre tm nt, hydrodynamic cavitation, and electromagnetic, gamm rays or mic owave
irr diation [21–23]. However, thes methods have been scarc ly investigated and are not
well-suited for producing well-defin d COS mixtures.
Che ical procedures for COS preparation comprise degradative methods, such as
chitin or chitosan depoly erization by acid hydrolysis or oxidation, and che ical synthe-
sis strategies. cid hydrolysis is the ost e ployed ethod for COS production at an
industrial scale and involves the use of hydrochloric acid, nitrous acid, phosphoric acid or
hydrogen fluoride [24]. The oxidative-reductive depolymerization is also widely applied
and generally relies on the use of hydrogen peroxide, persulfate or sodium nitrite [25]. Both
alternatives give rise to heterogeneous COS mixtures with typically low degrees of polymer-
ization. In addition, they are environmentally risky and generate detrimental byproducts
that make COS not suitable for human consumption due to possible contamination and
toxicity. Chemical methods for the synthesis of COS have progressed substantially in the
last decades, but they usually result in low yields and may require protection/deprotection
steps and the use of hazardous chemicals [26].
Enzymatic production of COS is very attractive since it requires milder conditions
(relatively low temperatures and slightly acidic pH) and does not generate harmful byprod-
ucts or wastes [27], which makes it safer and more environmentally friendly approach [28].
In addition, strategies based on biocatalysis present a higher efficiency and allow easier
control of the product composition due to inherent enzyme specificity. However, the
physicochemical properties of the substrate substantially affect the chemical composition
of the final product.
Enzymatic depolymerization of chitin or chitosan can be catalyzed by several gly-
coside hydrolases (GHs), including specific enzymes, such as chitinases [29,30] and chi-
tosanases [31,32], as well as nonspecific enzymes like other glycosidases (cellulases, gly-
canases, pectinases, muramidase, etc.), proteases, and lipases [16,33,34].
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Chitinases (EC 3.2.1.14) occur in families GH18, GH19 and GH20 [35] and are able to
hydrolyze GlcNAc-GlcNAc linkages [36,37]. Family GH18 comprises bacterial and fungal
chitinases [38], while family GH19 mainly contains plant chitinases. Chitinases can be
classified, according to their mode of action, into three major groups: (1) endo-chitinases,
(2) exo-chitinases and (3) β-N-acetylglucosaminidases. Glycosidases belonging to families
GH18 and GH19 are considered endo-chitinases since they catalyze the depolymerization
of chitin. Family GH20 only includes exo-chitinases and β-N-acetylglucosaminidases.
COS production requires the action of endo-chitinases, whereas N-acetyl-glucosamine
preparation entails the use of exo-chitinases and β-N-acetylglucosaminidases. Chitinases
are also capable of hydrolyzing both GlcNAc-GlcN and GlcN-GlcNAc linkages, enabling
chitosan depolymerization, although to a lesser extent than chitosanases. GH18 chitinases
require a GlcNAc moiety at subsite -1 [39], whereas GH19 chitinases have no necessity
for GlcNAc at this subsite. For this reason, chitinases belonging to family GH18 give rise
to COS with GlcNAc residues at their reducing ends [40]. On the other hand, oligomers
produced by GH19 chitinases can present N-acetylated or deacetylated reducing ends.
Chitosanases (EC 3.2.1.132) belong to the families GH5, GH7, GH8, GH46, GH75 and
GH80 [41] and are commonly found in soil microbes (both bacteria and fungi) [20,42].
According to their cleavage sites, chitosanases can be classified into two main categories:
endo-chitosanases, which are employed for COS production; and exo-chitosanases, which
cleave glucosamine residues from the nonreducing end of the substrate. Considering their
specificity, three subclasses of chitosanases can be distinguished: (1) chitosanases comprised
in class I can carry out the hydrolysis of both GlcNAc-GlcN and GlcN-GlcN bonds; (2)
class II chitosanases exclusively cleave GlcN-GlcN linkages; (3) chitosanases belonging to
class III can split both GlcN-GlcNAc and GlcN-GlcN linkages [43]. Although the yields
reported for the hydrolysis of chitosan by chitosanases are notable, the development of
more efficient strains that produce these enzymes constitutes a challenge [3,44].
Besides chitinases and chitosanases, other nonspecific enzymes have shown the ability
to recognize glycosidic bonds of chitin and/or chitosan and hydrolyze them [45], although
the activity can be one or two orders of magnitude lower than the obtained with specific
enzymes [17]. Among these enzymes, most studies have been carried out with other
glycosidic enzymes, mostly glycosidases (cellulases, lysozyme, pectinases, amylases, etc.),
but also with proteases and lipases [31,33]. However, most of these enzyme preparations are
not purified and derive from organisms that could produce chitosanolytic enzymes. Thus,
it cannot be discarded that in the case of enzymes of very different nature (e.g., proteases,
lipases, amylases, etc.), the presence of a contaminant enzyme is, in fact, responsible for the
activity [46]. Nevertheless, commercial preparations have several advantages, including
availability, lower cost, and the approval for employment in food processes. Although
some nonspecific enzymes give rise to a limited degradation of chitosan, the synergistic
action of these enzymes with specific chitosanases can favor COS preparation with a narrow
size distribution [3]. More recently, lytic chitin monooxygenases (LPMOs, EC 1.14.99.53) are
being investigated as auxiliary enzymes for COS synthesis, as they can break down β(1→4)
bonds in crystalline chitin by oxidation, thus facilitating the attack by chitinases [47].
In addition, a few chitosanases and GH18 chitinases have shown a certain degree of
transglycosylation activity, which means that they are capable of transferring the released
oligosaccharide residue to a suitable acceptor generating new glycosidic linkages and
forming specific COS [48,49].
Several factors can influence the outcome of a polysaccharide degradation reaction.
Considering COS preparation, both the selection of enzyme and the choice of substrate
exert a significant influence on the obtained products.
3. Types of Chitooligosaccharides
As previously mentioned, three types of COS can be prepared (Figure 1). In the following
paragraphs, we will give some guidelines to direct the synthesis towards a specific family
of compounds.
Appl. Sci. 2021, 11, 3212 5 of 14
3.1. Fully Deacetylated Chitooligosaccharides (fdCOS)
The preparation of fdCOS can be carried out employing chitosanases [50] or some
commercial preparations [16], but it generally requires a highly deacetylated chitosan as
a substrate or a chitin deacetylase [2]. In our laboratory, two approaches were studied to
obtain fdCOS: (1) the use of unspecific enzymes [46,51]; (2) the extraction of a chitosanolytic
activity from the preparation of Bacillus thuringiensis used as a pesticide [20].
In the first case, several commercial enzyme cocktails were screened for chitosanolytic
activity. Among the positives found, the proteolytic preparation Neutrase 0.8 L from
B. amyloliquefaciens was selected because our goal was to obtain fully deacetylated prod-
ucts, and some proteases had demonstrated the ability to hydrolyze N-acetyl residues
in chitosan [52,53]. A highly deacetylated (DD > 90%) chitosan (CHIT600) was chosen
to favor the formation of fdCOS. After 24 h of reaction, the products were characterized
by high-performance anion-exchange chromatography with pulsed amperometric detec-
tion (HPAEC-PAD) and matrix-assisted laser desorption/ionization with time-of-flight
detection (MALDI-TOF) mass spectrometry. The main components were identified as
glucosamine, chitobiose, chitotriose, chitotetraose and chitopentaose, and the deacetylation
degree of the reaction mixtures was always between 95 and 100% [46].
The second approach to obtain fdCOS was the use of an enzyme extract obtained
from commercial preparations of B. thuringiensis [20]. This preparation was assayed with
different chitosans, and we observed that the higher reaction rates were obtained with, the
more deacetylated chitosan (CHIT600), suggesting a higher specificity for deacetylated
substrates (chitosanase activity). After 72 h, the main reaction product was chitotetraose,
with significant amounts of chitobiose, chitotriose and chitopentaose (Figure 3). The yield
of identified deacetylated chitooligosaccharides was nearly 97%.
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The production of faCOS is usually performed with chitin as substrate, but due to chitin
crystallinity and insolubility in aqueous media, pretreatment is necessary. Generally, chitin
flakes are treated with strong acids and transformed into colloidal or swollen chitin [18]. In
addition, chitinases or lysozyme are normally employed for chitin depolymerization [54,55].
Our group studied the preparation of fully acetylated COS employing colloidal chitin
and chitinase Chit42, a recombinant enzyme from Trichoderma harzianum [39] that belongs
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to the GH18 family. The hydrolysis of colloidal chitin with chitinase Chit42 for 24 h mainly
yielded N-acetyl-chitobiose, N-acetyl-glucosamine and N-acetyl-chitotriose. In addition,
trace amounts of N-acetyl-chitotetraose were found. Products were characterized by
HPAEC-PAD and MALDI-TOF mass spectrometry (Figure 4), and the DD of the synthesized
COS was lower than 5%.
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assisted laser desorption/ionization with time-of-flight detection (MALDI-TOF) mass spectrometry.
Correspondence to HPAEC-PAD peaks is shown in parenthesis. Adapted with permission from [39].
3.3. Partially Acetylated Chitooligosaccharides (paCOS)
Several approaches can be followed for the preparation of partially acetylated COS. For
example, chitosan degradation with a low degree of deacetylation (DD between 70 and 85%)
by chitosanases could probably yield a high amount of paCOS. However, the combination of
this type of chitosans with GH18 chitinases could be more effective because these enzymes
require at least one GlcNAc moiety at t e -1 positio in the active site, thus assuring the
presenc in the synthesiz d products of a GlcNAc residue on their reducing ends.
The production of paCOS wa studied by our group employing chitosa with a
moderate DD (81%) and chitinase Chit42 from T. harzianum. The characterization of this
kind of COS is quite complex due to the lack of com ercial standards. HPAEC-PAD
analysis reveale the pres nce of at least 11 unide tified peaks tha probably corre po ed
to paCOS, while MALDI-TOF analysis showed COS with DP ≤ 9, mainly composed of
GlcN residues a d normally at least one moiety of GlcNAc. A related endo-chitinase from
the sam microorganism (Chit33) was expressed in Pichia pastor s and produced a mixture
of fully and partiall cetylated COS from different chitinolytic materials. In particular, the
hydrolysis of chitosan yielded GlcN-(GlcNAc)2 as the major product [56].
In conclusion, it is possible t modulate the kind of syn hesized COS by selecting
the enzyme (chiti ases, chitosanase) and/or the substrate (in particular, the degree of
deacetylation). The different strategies are illustrated in Figure 5.
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(DP ≤ 6), ultrafiltration with a 1 kDa membrane was applied to some mixtures (option 1).
Size-exclusion chromatography, ion-exchange chromatography and tangential filtration
are also alternatives to ultrafiltration to fractionate COS [58,59]. In all cases, salts and small
contaminants were eliminated by dialysis with 100 Da tubing, and COS fractions were
freeze-dried.
This common methodology (with slight modifications) was employed for the de-
polymerization of chitosan. Depending on the characteristics of the chitosan (DD, PA,
DP) and the enzyme used, different reaction outcomes were obtained (Figure 6). Conse-
quently, we were able to prepare a mixture of majorly fdCOS with MW ≤ 1 kDa, a mixture
mainly containing paCOS with MW ≤ 1 kDa, and a mixture of fdCOS and paCOS with
MW ≤ 10 kDa.
Enzyme immobilization is a powerful tool that can facilitate the scaling-up of many
biocatalytic processes [60], including those involved in the production of bioactive oligosac-
charides [61]. This technology makes enzyme recovery and the reuse of the biocatalysts
easier, and it usually increases the operational stability of the enzymes [62]. In this context,
we recently immobilized chitinase Chit42 from T. harzianum onto different carriers: (1)
magnetic nanoparticles; (2) chitosan beads with glutaraldehyde or genipin linkers [63]. The
immobilized biocatalysts showed improved operational stability and were applied to the
synthesis of COS from colloidal chitin and several chitosans. We demonstrated that the
biocatalysts were easy to handle and separate from the reaction mixture and thus could
be reused.
We have also investigated the continuous production of COS in packed-bed reactors.
For such purpose, we selected a chitosanolytic activity present in a commercial α-amylase
preparation (BAN), which was covalently immobilized onto glyoxal agarose beads [51]. The
immobilization did not change the product profile but increased the enzyme thermostability.
We developed a two-step process in which (1) chitosan was first hydrolyzed in a batch
reactor to reduce the viscosity; (2) the pretreated chitosan was pumped through a packed-
bead reactor (PBR) with immobilized enzyme, thus avoiding clogging of the column.
5. Bioactive Properties of COS
COS are natural antioxidants [9]. Several studies in vivo have proved that COS can
inhibit reactive oxygen species (ROS) and, in consequence, different pathways of the cell
damage caused by oxidative stress [64,65]. The molecular mechanism that explains the
antioxidant activities of the different COS families has not been completely elucidated [3],
although it was postulated that free amino groups of chitosan could interact with free
radicals giving rise to stable macroradicals. COS probably display their biological actions
by modulating different targets. Interestingly, COS with a molecular mass lower than 5 kDa
have displayed the highest antioxidant activities [66].
COS display a myriad of bioactivities, including neuroprotective [67], anti-inflammatory [12],
antihypertensive [68], antimicrobial [69], antiviral [70], antiangiogenic [71], antitumor [72] and
prebiotic [19,73].
The reported results on the bioactivity of COS reflect clear discrepancies, which can be
explained by the heterogeneity of the synthesized oligosaccharide samples and the use of
different bioassays. In many cases, the chemical composition and molecular weight of COS
are not fully determined before the assay. To obtain a reproducible product for bioassays,
the raw materials and the extent to which the substrate hydrolysis is allowed to proceed
should be carefully controlled.
COS have shown antimicrobial activity against bacteria, filamentous fungi and
yeasts [15,74]. The advantage of COS vs. chitosan is that the former can be used at pH > 6.5,
whereas the polymer is insoluble in water. In this context, COS have been proposed as
polycationic biocides [66]. The mechanism by which COS inhibit microbial growth could
be related to the interaction of free NH2 groups of glucosamine moieties with carboxylic
residues present in the outer cell membranes of microorganisms [33,75]. On the other hand,
Sanchez et al. reported that partially acetylated COS (paCOS) exhibit better antibacterial
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activity towards Listeria monocytogenes and Escherichia coli than fully deacetylated COS
(fdCOS), suggesting the essential role of acetamide moieties in the antimicrobial properties
of these compounds [76].
COS is also able to induce the resistance of plants and animals towards various viral
infections [70,77]. Although the mechanism is still unclear, the reduction of infectivity
could be associated with a minor absorption of virus onto the cell membrane.
The molecular features that determine the anti-tumor activity of COS have not been
elucidated yet. However, Huang et al. postulated that electrostatic interactions between
tumor cells and polycationic chitosan oligosaccharides could alter the membrane perme-
ability of such cells [78]. COS possess great potential as immunostimulatory agents in
novel anticancer therapies [79]. The fermentation of COS in vitro and its effect on human
fecal microbial community structure and metabolites have been recently reported [80]. In
other contexts, COS and their derivatives can be employed in drug delivery of anticancer
drugs [81].
Effect of COS Composition on Anti-Inflammatory Properties
The role that inflammation plays in the course of various pathologies, such as can-
cer and autoimmune diseases, is well reported [82]. The anti-inflammatory activity of
three COS mixtures, enriched in fdCOS, paCOS and faCOS, respectively, was assayed by
our group to assess the influence of COS nature on the activity [83]. This was investi-
gated by measuring the decrease in the levels of TNF-α (tumor necrosis factor) in murine
macrophages (RAW264.7) after stimulation with a mixture of lipopolysaccharides (LPS).
The amount of TNF-α was measured at different times upon incubation with 10 ng/well
of LPS. TNF-α reached its highest concentration after 6 h post-stimulation with LPS (data
not shown).
The secretion of TNF-α decreased during the first 6 h in macrophages treated with the
three COS mixtures in comparison with macrophages stimulated with LPS only (Figure 7).
These results confirmed the inhibitory effect of COS against inflammation. Figure 7 shows
the results using 250 ng of COS per well, which was the best of the assayed concentrations.
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6. Conclusions
COS have a wide variety of biological activities, which explain the potential of these
molecules in the food, pharmaceutical, cosmetic or agricultural industries. However, these
properties are influenced by the chemical composition of the oligosaccharides, in partic-
ular their size, deacetylation degree and pattern of acetylation. Therefore, the selective
synthesis of well-characterized COS mixtures is of great value for a deeper understand-
ing of their bioactivity and thus their future applications. The appropriate selection of
the chitin/chitosan feedstock and the enzyme source, in particular its chitinolytic or chi-
tosanolytic profile, is essential to direct the synthesis towards a particular type of COS.
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